ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 171 filers reported holding ZAI LAB LTD in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,938 | -71.1% | 106,171 | -65.2% | 14.16% | -39.8% |
Q1 2023 | $10,154 | -19.9% | 304,820 | -25.6% | 23.52% | -14.3% |
Q4 2022 | $12,680 | -99.8% | 409,574 | +82.1% | 27.44% | +1.3% |
Q3 2022 | $7,959,000 | -17.7% | 224,859 | -22.0% | 27.09% | +35.8% |
Q2 2022 | $9,675,000 | -36.5% | 288,208 | -18.1% | 19.94% | +0.4% |
Q1 2022 | $15,234,000 | +213.9% | 351,829 | +387.1% | 19.86% | +580.2% |
Q4 2021 | $4,853,000 | -95.5% | 72,230 | -92.9% | 2.92% | -91.0% |
Q3 2021 | $107,655,000 | -45.6% | 1,018,016 | -10.3% | 32.31% | -28.4% |
Q2 2021 | $197,928,000 | +40.8% | 1,135,367 | +6.7% | 45.15% | -13.6% |
Q1 2021 | $140,528,000 | -25.4% | 1,064,440 | -25.3% | 52.24% | +42.3% |
Q4 2020 | $188,343,000 | +40.8% | 1,424,632 | -13.8% | 36.72% | +8.2% |
Q3 2020 | $133,763,000 | -4.8% | 1,652,820 | -5.5% | 33.95% | -19.9% |
Q2 2020 | $140,561,000 | +82.1% | 1,749,184 | +17.2% | 42.38% | -2.0% |
Q1 2020 | $77,177,000 | +123.4% | 1,492,649 | +80.1% | 43.26% | +137.3% |
Q4 2019 | $34,542,000 | – | 828,949 | – | 18.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRILLIANCE ASSET MANAGEMENT LTD | 1,631,887 | $71,770,000 | 28.24% |
Zeal Asset Management Ltd | 351,829 | $15,234,000 | 19.86% |
Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $20,231,000 | 11.97% |
INDUS CAPITAL PARTNERS, LLC | 291,026 | $12,799,000 | 5.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $16,958,000 | 3.82% |
HSG Holding Ltd | 694,634 | $30,550,000 | 3.81% |
EcoR1 Capital, LLC | 2,223,212 | $97,777,000 | 3.06% |
Segantii Capital Management Ltd | 2,252,274 | $99,055,000 | 2.86% |
Privium Fund Management B.V. | 226,752 | $9,973,000 | 2.20% |
Genesis Investment Management, LLP | 820,352 | $36,079,000 | 2.12% |